The aim of this study was to evaluate and compare the performance of customised Acute Physiology and Chronic Health Evaluation II (APACHE II) and Simplified Acute Physiology Score II (SAPS II) in predicting hospital mortality of mixed critically ill Thai patients in a medical intensive care unit. A prospective cohort study was conducted over a four-year period. The subjects were randomly divided into calibration and validation groups. Logistic regression analysis was used for customisation. The performance of the scores was evaluated by the discrimination, calibration and overall fit in the overall group and across subgroups in the validation group. Two thousand and forty consecutive intensive care unit admissions during the study period were split into two groups. Both customised models showed excellent discrimination. The area under the receiver operating characteristic curve of the customised APACHE II was greater than the customised SAPS II (0.925 and 0.892, P <0.001). Hosmer-Lemeshow goodness-of-fit showed good calibration for the customised APACHE II in overall populations and various subgroups but insufficient calibration for the customised SAPS II. The customised SAPS II showed good calibration in only the younger, postoperative and sepsis patients subgroups. The overall performance of the customised APACHE II was better than the customised SAPS II (Brier score 0.089 and 0.109, respectively). Our results indicate that the customised APACHE II shows better performance than the customised SAPS II in predicting hospital mortality and could be used to predict mortality and quality assessment in our unit or other intensive care units with a similar case mix.
Severity scoring systems were developed to predict the outcomes of groups of critically ill patients admitted to an intensive care unit (ICU) but have also been used for several other purposes, for example in clinical trials to demonstrate study equivalency, to control groups of patients for study enrolment and for risk stratification in outcome comparisons 1 . Severity-adjusted outcome has been used to bench-mark baseline values in evaluating ICU performance in individual ICUs or to estimate comparison between ICUs of similar case mix 2 .
Several studies have reported a poor performance of the Acute Physiology and Chronic Health Evaluation II (APACHE II) and Simplified Acute Physiology Score II (SAPS II) in predicting mortality in a new population and/or different case mix [3] [4] [5] [6] [7] [8] [9] [10] . There could be several reasons for this poor calibration, such as variations in the case mix and/ or quality of care, varying quality of data collection and errors in the application of scores.
Customisation or recalibration of severity scores has been found useful when calibration is poor, especially for application to a specific ICU or group of patients [11] [12] [13] [14] [15] [16] [17] [18] [19] . A previous study found that APACHE II and SAPS II scores had poor calibration in predicting hospital mortality in critically ill patients in Thailand 9 . Therefore, the APACHE II and SAPS II scores were customised to improve their ability in predicting outcomes.
The aim of the present study was to evaluate the performance of APACHE II and SAPS II after customisation and to evaluate the scores from recalibration in their ability to predict hospital mortality of mixed critically ill patients in a medical ICU (MICU) at a tertiary referral university hospital in southern Thailand.
MATERIALS AnD METHoDS
This study was conducted in the MICU of Songklanagarind Hospital, an 854-bed tertiary referral university teaching hospital at Prince of Songkla University in Songkhla Province, southern Thailand. In our hospital, the MICU is a 10-bed mixed medical and coronary care unit serving all critically ill patients from the department of internal medicine.
All the data were collected concurrently from consecutive ICU admissions between 1 July 2004 and 30 June 2008. Patients were excluded if they were younger than 15 years, stayed in ICU less than eight hours or were readmitted during the study period. This study was approved by the Institutional Ethics Committee.
The following data for all components of the APACHE II 20 and SAPS II 21 were collected: gender, age, chronic health conditions, diagnostic category leading to ICU admission and the worst values physiological data during the first 24 hours following ICU admission. Patients were followed up until hospital discharge and their survival status was registered.
In order to customise and validate the customised APACHE II and SAPS II, the study population was randomly split into calibration and validation groups using the random sample function of the statistical program. The validation group was used to study the performance of the customised models. Logistic regression analysis was used for the calculation of new coefficients for the predictor variables of APACHE II and SAPS II. Hospital mortality was the dependent outcome variable.
The performance of the customised models was evaluated by discrimination, calibration and overall fit in the overall group and across subgroups in the validation group. Discrimination (the ability of the model to distinguish between survivors and nonsurvivors) was examined by using the area under the receiver operating characteristic curve (AURoC) 22 . Calibration (the degree of agreement between predicted mortality determined by the model and actual mortality) was tested using the Hosmer-Lemeshow goodness-of-fit H and C statistics 23 , calibration curve analysis and standard mortality ratio. The degrees of freedom (df) 8 and 10 were used to evaluate the calibration by the Hosmer-Lemeshow statistics in the calibration and validation groups, respectively. A P value >0.05 was accepted as indicating a good fit of the model. Calibration curves were constructed by plotting predicted mortality rates versus actual mortality rates after stratifying patients by 10% increments of predicted mortality. The overall fit of the model was assessed by Brier score. For perfect prediction, the Brier score was 0; for constant predictions of 0.5, each individual Brier score was 0.25 24 . Data are presented as median with interquartile range and the comparison between calibration and validation groups was done by wilcoxon's rank sum test, because values were not normally distributed. Chisquare was used to test for the statistical significance of categorical variables. Statistical significance was defined as P <0.05. Data were computerised using EpiData 3.21 software (The EpiData Association, Denmark) and analysed using Stata 7 software (StataCorp, College Station Texas, USA).
RESULTS
The new customised equations for APACHE II were:
Logit=-7.193+(APACHE II score×0.177)+(0.215 if emergency surgery)+new diagnostic category weight (see Appendix on the website version)
The new customised equations for SAPS II were: Logit=-14.149 + 0.033 (SAPS II score) + 3.016 (ln
The transformation of the logit into a probability was achieved by applying the formula:
Probability of hospital death (R)=e logit /(1+e logit ) A total of 2040 patients were enrolled during the study period. overall, 406 patients (19.9%) died in the ICU and 553 patients (27.1%) died in the hospital. The demographic and clinical characteristics of patients were similar for the calibration and validation groups (Table 1 ) and no significant differences were detected.
The performance of the original and customised APACHE II and SAPS II are presented in Table 2 . The AURoC of the customised APACHE II was greater than the original APACHE II (P=0.02). However, the discrimination power of SAPS II was unchanged following the customisation. The AURoC of the customised APACHE II was statistically significantly greater than the customised SAPS II (P <0.001). The receiver operating characteristic curves for both customised scores are shown in Figure 1 . The calibrations of the original APACHE II and SAPS II were poor because they strongly overpredicted mortality ( P values of 0.66. In contrast, the customised SAPS II exhibited poor calibration with Hosmer-Lemeshow goodness-of-fit H chi-square=50.62 (P <0.001). The calibration curves for the customised APACHE II and SAPS II are shown in Figure 2 . The customised APACHE II calibration curve accurately predicted mortality in five groups of patients and over-estimated mortality in predicted hospital deaths at 20%, 30% and 50% and under-estimated in other strata. The customised SAPS II calibration curve accurately predicted mortality in only three groups of patients and under-estimated mortality in the predicted mortality more than 80% but over-estimated in other strata. Table 3 . Both models showed good discrimination in all subgroups, except in coronary artery disease patients and patients with an ICU length of stay more than two days for the customised SAPS II. The AURoC of the customised APACHE II was statistically significantly greater than the customised SAPS II in the subgroups of male, age >60 years, medical patients and patients with ICU length of stay more than two days (P=0.015, 0.003, <0.001 and <0.001, respectively). The fit was uniform for the customised APACHE II in all subgroups according to gender, age group, ICU length of stay, type of admission and main diagnosis. However, the customised SAPS II showed good calibration only in the subgroups of younger age, postoperative and sepsis patients. The overall performance of the customised APACHE II was better than the customised SAPS II in all subgroups, except postoperative patients.
Subgroup analysis of the validation sample is shown in

DISCUSSIon
This study showed that customisation of the APACHE II with a new logistic regression equation gave good calibration and overall fit in predicting hospital mortality of a large group of mixed critically ill patients in our MICU. A similar customisation of SAPS II scores did not improve the accuracy of prediction outcome overall and in some subgroups of the tested patients.
For useful application of a severity scoring systems to an independent population from the original database (external validation), the accuracy of the predictions must be evaluated. A previous study in our hospital found that APACHE II and SAPS II showed poor calibration in that they over-estimated hospital mortality, with standard mortality ratios of 0.77 for both scores 9 . A similar poor calibration of APACHE II and SAPS II in external data sets has been documented in earlier studies [3] [4] [5] [6] [7] [8] [9] [10] . Customisation has been suggested as one possible approach when the model does not perform well. There are two main approaches to customisation, a first-level customisation, which requires computing a new logistic formula maintaining the same variables with the same weights as in the original model, and a second-level customisation, which involves reevaluation of the components or addition of new variables or both.
The results of our study are comparable with earlier studies in which customised severity scoring systems improved overall goodness-of-fit [11] [12] [13] [14] [15] [16] [17] [18] . However, the present study is the first report of successful improved calibration in an overall population and uniformity of fit. Suistomaa et al 16 reported customised APACHE II and SAPS II had good calibration in their overall patient population but poor uniformity of fit with their ICU length of stay. Markgraf et al 13 showed customisation of APACHE II and III in a single unit led to an improvement in the overall calibration, but uniformity of fit in different subgroups was not achieved. Beck et al 8 18 divided their databases randomly into development and validation groups, as was done in our study, and performed customised SAPS II test. These customisations resulted in well-calibrated models, however uniformity of fit was not reported in Glance's study and was indicated to have been poor in the other studies.
There are several possible explanations for poor calibration of customised SAPS II. First, SAPS II does not have a diagnostic code for ICU admissions as does APACHE II, which may have an effect on predicting outcomes. Second, coronary and postoperative cardiac patients were excluded in the original SAPS II, while the present study included all these patients, and this could have influenced the performance of the SAPS II. on the positive side, some previous studies have found that SAPS II gave good performance in acute myocardial infarction 25, 26 , coronary care 27 and cardiac surgery patients 28 . Second level customisation or adding variables to the SAPS II is the other method used to improve performance 17 . we did not use second level customisation of SAPS II because of our small sample size and because the information components required for this customisation are not routinely recorded and would have taken considerable time to collect retrospectively. First level customisation is a more practical method for a single unit to improve the calibration of severity scores that are used for quality assessment and benchmarking.
we retained the logistic equation used in APACHE II without changes to preserve maximum similarity with the original model. However, the diagnostic categories had to be recodified and regrouped in groups where there were too few patients. Unlike the original APACHE II, we included postoperative coronary artery bypass graft in our model because the APACHE II had been used with some success to predict mortality in these patients 9, 29 .
There were several limitations to our study. First, a study involving a single ICU may show some bias concerning case mix, quality of ICU care and institutional policy. Therefore, our customised model may not fit well in other ICUs. Second, the relatively small sample size was not only insufficiently powered to demonstrate significant differences in subgroup analysis but was also a relevant limiting factor in the calibrations. Sample size can have a major influence on the measured calibrations when using the Hosmer-Lemshow goodness-of-fit test, as it has been shown that small samples results in an apparently good fit but large samples result in a poor fit 10, 30 .
In conclusion, a customised APACHE II showed improved performance in discrimination, calibration, overall fit and uniform of fit of mixed critically ill patients in our MICU and could be used with some confidence in predicting outcomes and ICU quality assessment in our ICU or others with a similar case mix. Further investigations should be conducted periodically for ongoing assessment of the performance of a specially customised APACHE II in order to ensure calibration is maintained.
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